SCHEMBL6294041

SCHEMBL6294041

O=C1CCNc2cc(Oc3ccccc3)ccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
HPGD P15428 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
POLB P06746 1/20 0.58
GAA P10253 1/20 0.58
ALOX15 P16050 1/20 0.58
ALOX12 P18054 1/20 0.58
CASP1 P29466 1/20 0.58
MPI P34949 1/20 0.58
HTT P42858 1/20 0.58
CASP7 P55210 1/20 0.58
HSD17B10 Q99714 1/20 0.58
MAOB P27338 6/20 0.54
MAOA P21397 5/20 0.54
NPC1 O15118 3/20 0.50
MAPT P10636 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294106 0.81 MAOB (0.61) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL30718037 0.80 ALDH1A1 (0.54) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL643543 0.80 ALDH1A1 (0.54) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL4714955 0.78 MAOB (0.44) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL4715922 0.74 DRD2 (0.49) ALDH1A1MAOBMAOANPC1NISCH
SCHEMBL1745079 0.74 GRM5 (0.53) CASP1CASP7HSD17B10MAOBMAOA
SCHEMBL7981969 0.74 MEN1 (1.00) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6585430 0.74 MEN1 (0.48) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL68581 0.73 MEN1 (0.61) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL30966017 0.72 MAOA (0.65) MAOBMAOAGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872827-B2 Somatostatin analogue compounds CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) 2005-03-29 US disclosed
US-20040019069-A1 Somatostatin analogue compounds CHEMBRIDGE CORPORATION 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019069-A1 Somatostatin analogue compounds SSTR2, SSTR1, SSTR4 ALDH1A1 3075/4885HPGD 4368/4885MEN1 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.